Persistence survey of Toxic Shock Syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Parsonnet, Jeffrey ^a   Hansmann, Melanie A ^c   Seymour, Jon L ^c   Delaney, Mary L ^b   DuBois, Andrea M ^b   Modern, Paul A ^a   Jones, Michaelle B ^c   Wild, John E ^d   Onderdonk, Andrew B ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d Hill Top Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; IMMUNOGLOBULIN G ANTIBODY; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; ANTITOXIN; BACTERIAL TOXIN; BACTERIUM ANTIBODY; ENTEROTOXIN; ENTEROTOXIN F, STAPHYLOCOCCAL;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BLOOD SMEAR; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM STAINING; HEALTH SURVEY; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MENSTRUATION; NOSE SMEAR; PHENOTYPE; RECTUM BIOPSY; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME; VAGINA SMEAR; ANAL CANAL; BIOSYNTHESIS; BLOOD; HETEROZYGOTE; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; NOSE; PREVALENCE; STAPHYLOCOCCUS INFECTION; TIME; VAGINA;

ADULT; ANAL CANAL; ANTIBODIES, BACTERIAL; ANTITOXINS; BACTERIAL TOXINS; CARRIER STATE; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MENSTRUATION; NOSE; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TIME FACTORS; VAGINA;

EID: 77955801662     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-249     Document Type: Article

References (44)

1. Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis 1989, 11(Suppl 1):S1-S7.
2. Gaventa S, Reingold AL, Hightower AW, Broome CV, Schwartz B, Hoppe C, Harwell J, Lefkowitz LK, Makintubee S, Cundiff DR, Sitze S, . the Toxic Shock Syndrome Study Group Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis 1989, 11(Suppl 1):S28-S34. the Toxic Shock Syndrome Study Group.
3. Todd JK, Wisenthal AM, Ressman M, Caston SA, Hopkins RS. Toxic shock syndrome II. Estimated occurrence in Colorado as influenced by case ascertainment methods. Am J Epidemiol 1985, 122:857-867.
4. Descloux E, Perpoint T, Ferry T, Lina G, Bes M, Vandenesch F, Mohammedi I, Etienne J. One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 cases. Eur J Clin Microbiol Infect Dis 2008, 27(1):37-43. 10.1007/s10096-007-0405-2, 17932694.
5. Garbe PL, Arko RL, Reingold AL, Graves LM, Hayes PS, Hightower AW, Chandler FW, Broome CV. Staphylococcus aureus isolates form patients with non-menstrual toxic shock syndrome. Evidence for additional toxins. JAMA 1985, 253:2538. 10.1001/jama.253.17.2538, 3981783.
6. Czerwinski BS. Variation in feminine hygiene practices as a function of age. J Obstet Gynecol Neonatal Nurs 2000, 29:625-33. 10.1111/j.1552-6909.2000.tb02076.x, 11110333.
7. Nelson E, Jordan M. Sensitive Export: Seeking New Markets for Tampons, P&G Faces Cultural Barriers. The Wall Street Journal 2000, A1.
8. Bergdoll MS, Crass BA, Reiser RF, Robbins RN, Lee AC, Chesney PJ, Davis JP, Vergeront JM, Wand PJ. An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome. Ann Intern Med 1982, 96:969-971.
9. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis 1981, 143:509-516.
10. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur J Immunol 2000, 30:3247-3255. 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D, 11093140.
11. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002, 8:1398-1404. 10.1038/nm800, 12436116.
12. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, Andersson U, Kotb M. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol 1996, 156:3057-3064.
13. Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El-Ahmedy O, Schwartz B, Kotb M. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999, 67:1871-1877. 96540, 10085030.
14. Parsonnet J, Hansmann MA, Delaney ML, Modern PA, DuBois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB. Prevalence of toxic shock syndrome toxin-1 producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Micro 2005, 43:4628-4634.
15. Parsonnet J, Sullivan C, Modern P, Wissemann K. Risk factors for TSS among European women: vaginal colonization with S. aureus and antibody to TSST-1. Proceedings of the European conference on toxic shock syndrome 1997, 72. London, The Royal Society of Medicine Press, Ltd, Arbuthnott J, Furman B.
16. Adesium AA, Singh D, Guness RI. Toxic shock syndrome toxin-1 (TSST-1) production and phage susceptibility of Staphylococcus aureus strains from human vaginas and anterior nares in Trinidad. Zentralbl Bakteriol 1994, 280:371-381.
17. Chow AW, Bartlett KH, Percival-Smith R, Morrison BJ. Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis 1984, 150:80-84.
18. Linnemann CC, Staneck JL, Hornstein S, Barden TP, Rauh JL, Boneventre PF, Buncher CR, Benting A. The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med 1982, 96:940-944.
19. Yarwood JM, Schlievert PM. Oxygen and carbon dioxide: Regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol 2000, 38(5):1797-1803. 86591, 10790102.
20. Sarafian SK, Morse SA. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbio 1987, 24:75-81.
21. Taylor D, Holland KT. Effect of dilution rate and Mg+2 limitation on toxic shock syndrome toxin-1 production by Staphylococcus aureus grown in defined continuous culture. J Gen Microbiol 1988, 134:719-723.
22. Wong AC, Bergdoll MS. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect Immun 1990, 58:1026-1029. 258577, 2108084.
23. Davis CC, Kremer MJ, Schlievert PM, Squier CA. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution and tissue damage. Am J Obstet Gynecol 2003, 189:1785-1791. 10.1016/S0002-9378(03)00873-1, 14710116.
24. Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, Parsonnet J. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun 1998, 56(1):135-41.
25. Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, Bergdoll MS. Prevalence of serum antibody to staphyloccocal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis 1983, 148:692-698.
26. Jacobson JA, Kasworm EM, Crass BA, Bergdoll MS. Nasal carriage of toxigenic Staphylococcus aureus and prevalence of serum antibody to toxic-shock-syndrome toxin 1 in Utah. J Infect Dis 1986, 153:356-359.
27. VandenBergh MFQ, Yzerman EPF, van Belkum A, Boelens HAM, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Micro 1999, 37(10):3133-3140.
28. Peacock SJ, Justice A, Griffiths D, de Silva GDI, Kantzanou MN, Crook D, Sleeman K, Day NPJ. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Micro 2003, 41(12):5718-5725.
29. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, McDougal LK, Chaitram J, Jensen B, Fridkin SK, Killgore G, Tenover FC. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006, 193:172-179. 10.1086/499632, 16362880.
30. Nouwen J, Boelens H, van Belkum A, Verbrugh H. Human factor in Staphylococcus aureus nasal carriage. Infect Immun 2004, 72(11):6685-6688. 10.1128/IAI.72.11.6685-6688.2004, 523019, 15501803.
31. Nouwen JL, Ott A, Kluytmans-Vandenbergh MFQ, Boelens HAM, Hofman A, van Belkum A, Verbrugh H. Predicting the Staphylococcus aureus nasal carrier state: derviation and validation of a "culture rule". Clin Infect Dis 2004, 39:806-811. 10.1086/423376, 15472812.
32. Kansal R, Davis C, Hansmann M, Seymour J, Parsonnet J, Modern P, Gilbert S, Kotb M. Structural and Functional Properties of Antibodies to the Superantigen TSST-1 and Their Relationship to Menstrual Toxic Shock Syndrome. J Clin Immunol 2007, 27(3):327-338. 10.1007/s10875-007-9072-4, 17340193.
33. Tavares D, Sa-Leo R, Miragaia M, Lencastre H. Large screening of CA-MRSA among Staphylococcus aureus colonizing healthy young children living in two areas (urban and rural) of Portugal. BMC Infectious Diseases 2010, 110. 10.1186/1471-2334-10-110, 2876167, 20438633.
34. Parsonnet J, Mills JT, Gillis ZA, Pier GB. Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin-1. J Clin Microbiol 1985, 22:26-31. 268314, 3926815.
35. Johnson WM, Tyler SD. PCR Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin-1 in Staphylococcus aureus. Diagnostic molecular microbiology principles and applications 1993, 294-299. Rochester MN, American Society for Microbiology, Persing DM, Smith TF, Tenover FC, White TJ.
36. Nilsson P, Ripa T. Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares. J Clin Micro 2006, 44(9):3334-3339.
37. Shuter V, Hatcher B, Lowy FD. Staphylococcus aureus binding to human nasal mucin. Infect Immun 1996, 64(1):310-318. 173761, 8557357.
38. Walsh EJ, O'Brien LM, Liang X, Hooks M, Foster TJ. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. Journal of Chemistry 2004, 279(49):50691-50699.
39. van den Akker ELT, Nouwen JL, Melles DC, van Rossum EFC, Koper JW, Uitterlinden AG, Hofman A, Verbrugh HA, Pols HA, Lamberts SWJ, Van Belkum A. Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 2006, 194:814-818. 10.1086/506367, 16941349.
40. Vesterlund S, Karp M, Salminen S, Ouwehand AC. Staphylococcus aureus adheres to human intenstinal mucus but can be displaced by certain lactic acid bacteria. Microbiology 2006, 152:1819-1826. 10.1099/mic.0.28522-0, 16735744.
41. Gill SR, Pop M, DeBoy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359. 10.1126/science.1124234, 16741115.
42. van Belkum A, Verkaik NJ, de Vogel CP, Boelens HA, Verveer J, Nouwen JL, Verbrugh HA, Werthiem HFL. Reclassification of Staphylococcus aureus nasal carriage types. J Infect Dis 2009, 199:1820-1826. 10.1086/599119, 19419332.
43. Thomas D, Dauwalder O, Brun V, Badiou C, Ferry T, Etienne J, Vandenesch F, Lina G. Staphylococcus aureus Superantigens Elicit Redundant and Extensive Human Vß Patterns. Infect Immun 2009, 77(5):2043-2050. 10.1128/IAI.01388-08, 2681734, 19255190.
44. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Kurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE. An immunogenetics and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med 2002, 8(12):1398-1404. 10.1038/nm800, 12436116.